Normal 0 false false false MicrosoftInternetExplorer4 Shares of NuPathe Inc. (NASDAQ: PATH) soared 10.5% to $3.67 after the specialty pharmacy company said the previous day that the U.S. Food and Drug Administration has approved its Zecuity drug for the acute treatment of migraines. Share volume was 541,000 an all-day average of 44,000 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}